NextCure, Inc.
NXTCDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How NXTC's past catalysts played out
Frequently asked questions
What is in NextCure, Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in NextCure, Inc.'s (NXTC) pipeline across Phase 2. Its lead program is NC318 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is NextCure, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NextCure, Inc. (NXTC) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NXTC biotech catalysts?→
Add NXTC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NextCure, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.